Neos Therapeutics, Inc

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

1 in Phase 3

Quick facts

Phase 3 pipeline

NT0102 · Psychiatry / Neurology
NT0102 is a prodrug formulation of methylphenidate designed to provide extended-release delivery with reduced abuse potential.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

Neos Therapeutics, Inc portfolio CI brief
Neos Therapeutics, Inc pipeline updates RSS

Frequently asked questions about Neos Therapeutics, Inc

What is Neos Therapeutics, Inc's pipeline?

Neos Therapeutics, Inc has 1 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include NT0102.

Sector hub: All tracked pharma companies